ELISHA TRAPP: Open Payments
NPI 1215504147 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 9 companies in 2025. Trend: 2023 $924 · 2024 $735 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Exact Sciences Corporation | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Philips North America LLC | 1 | $27 |
| Insmed, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $16 |
Products named: GLASSIA, DUPIXENT, NUCALA, Cologuard Collection Kit, Holter, Arikayce, YUPELRI, Zemaira.
Industry payments across IN — which companies pay providers there.
